Natwest may have spooked investors, but this Swiss bank reckons its still a 'buy'

NatWest agreed to acquire Evelyn Partners for £2.7bn (≈15.1x FY25 adj. EBITDA of £179m), a deal UBS says equates to about 130bps and has flagged £100m of targeted cost synergies. UBS retains a Buy rating with a 780p target (≈29% upside from 605p), while noting NatWest may struggle to hit an 11% ROIC by FY28 on a clean run‑rate; the acquisition nevertheless broadens the bank’s wealth and investment proposition and supports a faster-growing, higher-ROTE profile.

Analysis

Market structure: NatWest's £2.7bn Evelyn Partners buy (15.1x FY25 adj. EBITDA) immediately boosts NWG's wealth distribution, client AUM and cross-sell optionality, benefiting NatWest (NWG) and putting pressure on pure-play wealth managers (e.g., STJ.L, HL.L) where fee compression and client outflows are more visible. UBS's 780p target implies ~29% upside from 605p, so the market sell-off looks like a liquidity/valuation haircut rather than a fundamental impairment; expected £100m synergies materially lower net cash payback at 15.1x. Demand signal: continued investor preference for banks with diversified fee pools versus rate-sensitive lending books; supply-side implies further consolidation in UK wealth management over 12–36 months.

Risk assessment: Tail risks include failed integration leading to >20% impairment of goodwill, regulatory remedies or capital add (raising CET1 by >100bps equivalent), or AUM decline of >10% in a market shock that reduces ROIC below 8% by FY28. Time horizons: immediate (days) — elevated share volatility and options IV; short (weeks–months) — 4Q25 results and synergy cadence; long (quarters–years) — realization of ROIC/ROTE improvements by FY28. Hidden dependencies: adviser retention rates (need >90% to hit synergies), interest-rate path for NII, and execution risk on £100m cost saves.

Trade implications: Direct play — establish a 2–3% long position in NWG at 540–620p targeting 780p within 9–18 months, stop-loss 520p (cuts exposure if integration concerns surface). Pair trade — long NWG (2%) / short STJ.L (1.5%) to capture relative re-rating; unwind if NWG >780p or STJ.L outperforms by 15%. Options — buy a 12-month NWG 650/850 call spread (debit) sized to 0.5% portfolio to cap downside and retain upside to analyst re-rates around results.

Contrarian angles: Consensus underappreciates potential for cross-sell to lift NWG ROTE materially if adviser retention >92% and AUM grows 5–8% pa; conversely, market may be underestimating short-term capital dilution or dividend pressure if CET1 falls >80bps. Historical parallels: bank acquisitions initially punished (12–18 months) but often accretive by year three when synergies hit — use a 12–24 month horizon. Unintended consequences include management distraction reducing core bank focus and potential regulatory covenant triggers that would force asset sales or capital raises.

Key Decisions for Investors

• Establish a 2–3% long position in NatWest Group (NWG) at 540–620p, target 780p within 9–18 months, place a hard stop-loss at 520p to limit integration/stock-risk exposure.
• Implement a relative-value pair: long NWG (2% weight) and short St. James's Place (STJ.L) (1.5% weight); unwind if NWG >780p or STJ.L outperforms by 15% from trade entry, horizon 6–18 months.
• Buy a capped upside options trade: NWG 12‑month 650/850 call spread (expiry Feb 2027) sized at 0.5% portfolio — limits premium at risk while capturing recovery/upgrades tied to FY26–FY28 synergy proof points.
• Conditional risk action: if NatWest’s 4Q25 results (due Friday) fail to show at least £40–50m of near-term synergy visibility or management withdraws FY28 ROIC guidance, reduce NWG exposure by 50% within 3 trading days and rotate proceeds into higher-quality UK banks with >12% ROTE (e.g., monitor HSBC/HSBA for selective buys).